CN Stock MarketDetailed Quotes

Zhejiang Haisen Pharmaceutical (001367)

Watchlist
  • 26.49
  • -0.91-3.32%
Market Closed Apr 17 15:00 CST
4.04BMarket Cap29.70P/E (TTM)

Zhejiang Haisen Pharmaceutical (001367) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
Total operating revenue
12.88%532.26M
12.13%358.87M
14.93%242.09M
2.32%118.48M
18.63%471.51M
13.02%320.04M
8.93%210.64M
8.27%115.8M
-5.99%397.45M
-10.44%283.17M
Operating revenue
12.88%532.26M
12.13%358.87M
14.93%242.09M
2.32%118.48M
18.63%471.51M
13.02%320.04M
8.93%210.64M
8.27%115.8M
-5.99%397.45M
-10.44%283.17M
Other operating revenue
-39.12%587.92K
----
-5.82%407.79K
----
-17.36%965.74K
----
-53.80%432.99K
----
-28.82%1.17M
----
Total operating cost
14.47%381.2M
17.47%259.59M
18.86%172.7M
7.96%83.57M
19.91%333.03M
9.41%220.99M
3.15%145.3M
-0.08%77.41M
-8.61%277.74M
-10.13%201.98M
Operating cost
4.92%289.55M
4.07%195.28M
8.00%134.3M
-6.26%66.1M
17.84%275.96M
10.57%187.65M
5.40%124.36M
4.66%70.51M
-11.57%234.18M
-14.85%169.7M
Operating tax surcharges
5.08%4.58M
7.65%3.6M
2.81%2.32M
13.61%1.01M
4.75%4.36M
16.24%3.35M
7.46%2.25M
17.00%892.61K
95.38%4.16M
32.34%2.88M
Operating expense
31.17%16.2M
28.98%11.18M
12.18%6.74M
49.46%2.56M
18.06%12.35M
8.26%8.67M
14.19%6M
-10.76%1.71M
4.22%10.46M
4.69%8M
Administration expense
20.60%37.03M
41.09%25.68M
29.34%15.49M
38.25%7.01M
17.96%30.71M
-9.05%18.2M
-13.62%11.98M
5.29%5.07M
14.53%26.03M
18.35%20.01M
Financial expense
72.31%-5.02M
70.66%-4.31M
64.60%-3.85M
49.55%-2.55M
-13.74%-18.13M
-33.27%-14.69M
-76.41%-10.88M
-1,133.71%-5.06M
-37.70%-15.94M
-4.70%-11.03M
-Interest expense (Financial expense)
-7.40%346.05K
-7.15%259.16K
-6.36%172.79K
-7.94%84.93K
1,000.55%373.72K
986.72%279.12K
467.99%184.52K
467.99%92.26K
-49.99%33.96K
-50.28%25.68K
-Interest Income (Financial expense)
63.13%-5.68M
69.90%-4M
66.44%-3.08M
53.40%-1.92M
-0.75%-15.41M
-32.28%-13.28M
-68.25%-9.17M
-213.59%-4.12M
-330.91%-15.3M
-348.33%-10.04M
Research and development
39.89%38.86M
57.96%28.17M
52.83%17.71M
120.63%9.44M
47.44%27.78M
43.61%17.83M
48.10%11.59M
42.58%4.28M
19.50%18.84M
33.87%12.42M
Credit Impairment Loss
-2,610.71%-2.75M
-170.86%-566.72K
-205.41%-448.21K
182.19%45.09K
76.25%-101.55K
50,837.53%799.76K
151.35%425.21K
90.25%-54.86K
44.38%-427.52K
99.89%-1.58K
Asset Impairment Loss
80.24%-698.85K
32.50%-400.2K
52.91%-256.9K
95.52%-13.76K
-45.07%-3.54M
-21.81%-592.85K
-32.50%-545.51K
---306.99K
-107.81%-2.44M
41.90%-486.71K
Other net revenue
62.49%5.79M
13.28%2.92M
-58.51%843.08K
27.71%902.75K
57.62%3.56M
19.76%2.58M
309.42%2.03M
240.24%706.85K
-18.50%2.26M
53.63%2.15M
Fair value change income
--1.7M
----
----
----
----
----
----
----
----
----
Invest income
67.23%5.02M
1,426.94%2.66M
--568.73K
--213.66K
838.57%3M
--174.27K
----
----
110.30%319.69K
----
Asset deal income
----
----
----
----
----
----
----
----
---241.71K
---241.71K
Other revenue
-39.85%2.53M
-44.19%1.23M
-54.49%979.47K
-38.45%657.76K
-16.79%4.2M
-23.80%2.2M
8.82%2.15M
255.81%1.07M
-41.03%5.05M
-61.78%2.88M
Operating profit
10.42%156.85M
0.55%102.19M
4.23%70.23M
-8.40%35.81M
16.46%142.05M
21.95%101.63M
27.12%67.37M
34.91%39.1M
0.27%121.97M
-10.20%83.34M
Add:Non operating Income
-52.40%584.79K
801.06%571.27K
805.40%566.79K
724.29%501.17K
13,960.07%1.23M
856.46%63.4K
946.21%62.6K
974.10%60.8K
-99.78%8.74K
-99.83%6.63K
Less:Non operating expense
-54.78%673.27K
-72.32%397.45K
-31.31%298.55K
-52.00%125.02K
13.81%1.49M
203.90%1.44M
70.67%434.65K
196.84%260.46K
-29.89%1.31M
-49.40%472.43K
Total profit
10.56%156.76M
2.10%102.37M
5.21%70.49M
-6.97%36.19M
17.49%141.79M
20.98%100.26M
27.01%67M
34.60%38.9M
-2.51%120.68M
-13.57%82.87M
Less:Income tax cost
8.58%20.88M
6.38%14.16M
8.26%9.7M
-9.75%4.98M
20.11%19.23M
21.56%13.31M
29.05%8.96M
41.34%5.51M
-1.13%16.01M
-16.47%10.95M
Net profit
10.87%135.88M
1.45%88.21M
4.74%60.79M
-6.51%31.21M
17.09%122.56M
20.89%86.95M
26.70%58.04M
33.55%33.38M
-2.72%104.67M
-13.11%71.93M
Net profit from continuing operation
10.87%135.88M
1.45%88.21M
4.74%60.79M
-6.51%31.21M
17.09%122.56M
20.89%86.95M
26.70%58.04M
33.55%33.38M
-2.72%104.67M
-13.11%71.93M
Net profit of parent company owners
10.87%135.88M
1.45%88.21M
4.74%60.79M
-6.51%31.21M
17.09%122.56M
20.89%86.95M
26.70%58.04M
33.55%33.38M
-2.72%104.67M
-13.11%71.93M
Earning per share
Basic earning per share
10.98%0.91
1.72%0.59
5.13%0.41
-6.06%0.31
-27.43%0.82
-27.50%0.58
-29.09%0.39
-32.65%0.33
-46.45%1.13
-50.62%0.8
Diluted earning per share
8.54%0.89
0.00%0.58
2.56%0.4
-9.09%0.3
-27.43%0.82
-27.50%0.58
-29.09%0.39
-32.65%0.33
-46.45%1.13
-50.62%0.8
Other composite income
Total composite income
10.87%135.88M
1.45%88.21M
4.74%60.79M
-6.51%31.21M
17.09%122.56M
20.89%86.95M
26.70%58.04M
33.55%33.38M
-2.72%104.67M
-13.11%71.93M
Total composite income of parent company owners
10.87%135.88M
1.45%88.21M
4.74%60.79M
-6.51%31.21M
17.09%122.56M
20.89%86.95M
26.70%58.04M
33.55%33.38M
-2.72%104.67M
-13.11%71.93M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
Auditor
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023
Total operating revenue 12.88%532.26M12.13%358.87M14.93%242.09M2.32%118.48M18.63%471.51M13.02%320.04M8.93%210.64M8.27%115.8M-5.99%397.45M-10.44%283.17M
Operating revenue 12.88%532.26M12.13%358.87M14.93%242.09M2.32%118.48M18.63%471.51M13.02%320.04M8.93%210.64M8.27%115.8M-5.99%397.45M-10.44%283.17M
Other operating revenue -39.12%587.92K-----5.82%407.79K-----17.36%965.74K-----53.80%432.99K-----28.82%1.17M----
Total operating cost 14.47%381.2M17.47%259.59M18.86%172.7M7.96%83.57M19.91%333.03M9.41%220.99M3.15%145.3M-0.08%77.41M-8.61%277.74M-10.13%201.98M
Operating cost 4.92%289.55M4.07%195.28M8.00%134.3M-6.26%66.1M17.84%275.96M10.57%187.65M5.40%124.36M4.66%70.51M-11.57%234.18M-14.85%169.7M
Operating tax surcharges 5.08%4.58M7.65%3.6M2.81%2.32M13.61%1.01M4.75%4.36M16.24%3.35M7.46%2.25M17.00%892.61K95.38%4.16M32.34%2.88M
Operating expense 31.17%16.2M28.98%11.18M12.18%6.74M49.46%2.56M18.06%12.35M8.26%8.67M14.19%6M-10.76%1.71M4.22%10.46M4.69%8M
Administration expense 20.60%37.03M41.09%25.68M29.34%15.49M38.25%7.01M17.96%30.71M-9.05%18.2M-13.62%11.98M5.29%5.07M14.53%26.03M18.35%20.01M
Financial expense 72.31%-5.02M70.66%-4.31M64.60%-3.85M49.55%-2.55M-13.74%-18.13M-33.27%-14.69M-76.41%-10.88M-1,133.71%-5.06M-37.70%-15.94M-4.70%-11.03M
-Interest expense (Financial expense) -7.40%346.05K-7.15%259.16K-6.36%172.79K-7.94%84.93K1,000.55%373.72K986.72%279.12K467.99%184.52K467.99%92.26K-49.99%33.96K-50.28%25.68K
-Interest Income (Financial expense) 63.13%-5.68M69.90%-4M66.44%-3.08M53.40%-1.92M-0.75%-15.41M-32.28%-13.28M-68.25%-9.17M-213.59%-4.12M-330.91%-15.3M-348.33%-10.04M
Research and development 39.89%38.86M57.96%28.17M52.83%17.71M120.63%9.44M47.44%27.78M43.61%17.83M48.10%11.59M42.58%4.28M19.50%18.84M33.87%12.42M
Credit Impairment Loss -2,610.71%-2.75M-170.86%-566.72K-205.41%-448.21K182.19%45.09K76.25%-101.55K50,837.53%799.76K151.35%425.21K90.25%-54.86K44.38%-427.52K99.89%-1.58K
Asset Impairment Loss 80.24%-698.85K32.50%-400.2K52.91%-256.9K95.52%-13.76K-45.07%-3.54M-21.81%-592.85K-32.50%-545.51K---306.99K-107.81%-2.44M41.90%-486.71K
Other net revenue 62.49%5.79M13.28%2.92M-58.51%843.08K27.71%902.75K57.62%3.56M19.76%2.58M309.42%2.03M240.24%706.85K-18.50%2.26M53.63%2.15M
Fair value change income --1.7M------------------------------------
Invest income 67.23%5.02M1,426.94%2.66M--568.73K--213.66K838.57%3M--174.27K--------110.30%319.69K----
Asset deal income -----------------------------------241.71K---241.71K
Other revenue -39.85%2.53M-44.19%1.23M-54.49%979.47K-38.45%657.76K-16.79%4.2M-23.80%2.2M8.82%2.15M255.81%1.07M-41.03%5.05M-61.78%2.88M
Operating profit 10.42%156.85M0.55%102.19M4.23%70.23M-8.40%35.81M16.46%142.05M21.95%101.63M27.12%67.37M34.91%39.1M0.27%121.97M-10.20%83.34M
Add:Non operating Income -52.40%584.79K801.06%571.27K805.40%566.79K724.29%501.17K13,960.07%1.23M856.46%63.4K946.21%62.6K974.10%60.8K-99.78%8.74K-99.83%6.63K
Less:Non operating expense -54.78%673.27K-72.32%397.45K-31.31%298.55K-52.00%125.02K13.81%1.49M203.90%1.44M70.67%434.65K196.84%260.46K-29.89%1.31M-49.40%472.43K
Total profit 10.56%156.76M2.10%102.37M5.21%70.49M-6.97%36.19M17.49%141.79M20.98%100.26M27.01%67M34.60%38.9M-2.51%120.68M-13.57%82.87M
Less:Income tax cost 8.58%20.88M6.38%14.16M8.26%9.7M-9.75%4.98M20.11%19.23M21.56%13.31M29.05%8.96M41.34%5.51M-1.13%16.01M-16.47%10.95M
Net profit 10.87%135.88M1.45%88.21M4.74%60.79M-6.51%31.21M17.09%122.56M20.89%86.95M26.70%58.04M33.55%33.38M-2.72%104.67M-13.11%71.93M
Net profit from continuing operation 10.87%135.88M1.45%88.21M4.74%60.79M-6.51%31.21M17.09%122.56M20.89%86.95M26.70%58.04M33.55%33.38M-2.72%104.67M-13.11%71.93M
Net profit of parent company owners 10.87%135.88M1.45%88.21M4.74%60.79M-6.51%31.21M17.09%122.56M20.89%86.95M26.70%58.04M33.55%33.38M-2.72%104.67M-13.11%71.93M
Earning per share
Basic earning per share 10.98%0.911.72%0.595.13%0.41-6.06%0.31-27.43%0.82-27.50%0.58-29.09%0.39-32.65%0.33-46.45%1.13-50.62%0.8
Diluted earning per share 8.54%0.890.00%0.582.56%0.4-9.09%0.3-27.43%0.82-27.50%0.58-29.09%0.39-32.65%0.33-46.45%1.13-50.62%0.8
Other composite income
Total composite income 10.87%135.88M1.45%88.21M4.74%60.79M-6.51%31.21M17.09%122.56M20.89%86.95M26.70%58.04M33.55%33.38M-2.72%104.67M-13.11%71.93M
Total composite income of parent company owners 10.87%135.88M1.45%88.21M4.74%60.79M-6.51%31.21M17.09%122.56M20.89%86.95M26.70%58.04M33.55%33.38M-2.72%104.67M-13.11%71.93M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions Unqualified opinion------Unqualified opinion------Unqualified opinion--
Auditor Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More